Work

Optimizing graphene-enhanced polycaprolactone scaffolds for bone tissue engineering

Year: 2026

Type: article

Abstract: Polycaprolactone (PCL) is widely used in scaffold fabrication due to its biocompatibility and mechanical properties, yet its limited osteoinductive capability hinders effective bone regeneration. To address this, graphene (G) has been incorporated into PCL scaffolds to enhance bioactivity, mechanical strength, and osteogenic potential. This study evaluates the osteogenic efficacy of PCL/G composite scaffolds by analyzing osteocalcin (OCN) and osteopontin (OPN) expression and mineralization using Alizarin Red staining. Thirty-six adult male rabbits were randomized to four groups and evaluated on day 7, 14 and 21. The PCL/G scaffolds were fabricated using the solvent casting and particle leaching method. A left tibial incision was made and exposing the site for osteotomy. Scaffolds were implanted, and wounds closed. Expression of OCN and OPN were evaluated by immunochemistry and mineralization was evaluated by Alizarin Red staining. The results indicate that increasing graphene concentration significantly enhances osteogenic activity, with 2.5 wt% graphene demonstrating the highest OCN and OPN expression, as well as superior calcium deposition. These findings highlight the potential of graphene-based scaffolds in promoting bone regeneration and accelerating clinical translation. Future research should focus on long-term in vivo studies and scaffold degradation kinetics to validate their effectiveness in maxillofacial bone defects due to oral cancer surgery. • Osteocalcin (OCN) and osteopontin (OPN) are critical markers for bone formation, which reflects the progression of bone regeneration. • Incorporating graphene into PCL scaffolds enhances osteogenic activity in a dose-dependent manner. • The increased graphene content optimally supports cell adhesion, proliferation, differentiation, and bioelectrical signaling. • Graphene-enriched PCL scaffolds, especially at 2.5 wt% indicating strong potential for clinical applications in bone tissue engineering.

Source: Journal of Oral Biology and Craniofacial Research

DOI: 10.1016/j.jobcr.2026.101418